| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/07/2005 | US20050076396 Adipocyte progenitor cell for use as tool in bone marrow harvesting; tissue engineering and regenerative medicine |
| 04/07/2005 | US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics |
| 04/07/2005 | US20050075489 DSP-5 dual-specificity phosphatase |
| 04/07/2005 | US20050075488 Interleukin-1 beta antibodies |
| 04/07/2005 | US20050075487 Agents that bind to and inhibit human cytochrome P450 2C8, 2C9, 2C18 and 2C19 |
| 04/07/2005 | US20050075308 Methods and compositions for producing antigenic responses |
| 04/07/2005 | US20050075307 Modulation of aminopeptidase N expression |
| 04/07/2005 | US20050075268 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 04/07/2005 | US20050074888 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 04/07/2005 | US20050074885 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/07/2005 | US20050074881 Chronic pathogen-expressing cell lines |
| 04/07/2005 | US20050074880 Generation of multipotent central nervous system stem cells |
| 04/07/2005 | US20050074877 Joint propagated on biological scaffold for use in treatment and prevention of degenerative bone disorders; tissue engineering and regenerative medicine |
| 04/07/2005 | US20050074876 Cultured, immortalized, non-transformed mammalian hepatic cell line for use as tool in treatment of disease; tissue engineering and regenerative medicine |
| 04/07/2005 | US20050074875 Methods of tissue repair and regeneration and tissue engineered compositions |
| 04/07/2005 | US20050074874 Unique properties of a stem cells |
| 04/07/2005 | US20050074853 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 04/07/2005 | US20050074852 Serine/threonine kinase (PKN) peptides for use in identifying modulators for treatment and prevention of inflammation, cancer, arteriosclerosis and psoriasis |
| 04/07/2005 | US20050074843 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/07/2005 | US20050074842 Membrane protein for use as tools in generation of vaccine; medical diagnosic and drug screening tools |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074839 Novel survivin interacting protein tpr1 |
| 04/07/2005 | US20050074838 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 04/07/2005 | US20050074837 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074766 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074756 FALP proteins |
| 04/07/2005 | US20050074744 Articular cartilage graft for use as tool in monitoring efficacy of modulators for treatment arthritic bone disorders |
| 04/07/2005 | US20050074742 Engineered bone tissues propagating on growth matrix; tissue engineering and regenerative medicine |
| 04/07/2005 | US20050074477 Method for the treatment of diseased, degenerated, or damaged tissue using three dimensional tissue produced in vitro in combination with tissue cells and/or exogenic factors |
| 04/07/2005 | US20050074476 Surgical implants utilizing blood stem cells |
| 04/07/2005 | US20050074439 Utilized for expression of desired heterologous DNAs |
| 04/07/2005 | US20050074438 Peptidyl prolyl cis trans isomerase activity; antioxidants; preventing transplant rejection; myoblast cell line |
| 04/07/2005 | US20050074436 Systems and methods for treating patients with processed lipoaspirate cells |
| 04/07/2005 | US20050074435 Enriching stem and progenitor cells by positive or negative selection of hematopoietic cells from umbilical cord blood; culturing under proliferation conditions that increase differentiation potential |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
| 04/07/2005 | DE10338531A1 Verfahren zur Reklonierung von Produktionszellen Process for the production of cell-cloning |
| 04/07/2005 | DE10336152A1 Aufreinigungsverfahren für mesenchymale Stammzellen Purification method for mesenchymal stem cells |
| 04/07/2005 | CA2540706A1 Royal jelly peptide and composition containing the same |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2540283A1 Tumor vaccine |
| 04/07/2005 | CA2540049A1 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 04/07/2005 | CA2539947A1 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 04/07/2005 | CA2539837A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2539716A1 Compositions and methods to accelerate hematologic recovery |
| 04/07/2005 | CA2537876A1 Antibodies to m-csf |
| 04/07/2005 | CA2537363A1 Synthetic heparanase molecules and uses thereof |
| 04/07/2005 | CA2537340A1 Leader sequences for use in production of proteins |
| 04/07/2005 | CA2537335A1 Use of antisecretory factor for neuroprotection |
| 04/06/2005 | EP1520860A2 Recombinant protein PilC, method for its production and use thereof |
| 04/06/2005 | EP1520583A2 NKT cell-activating agents containing alpha-glycosylceramides |
| 04/06/2005 | EP1520157A1 A method of studying living cells |
| 04/06/2005 | EP1520024A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 04/06/2005 | EP1520019A2 Adapter-directed display system |
| 04/06/2005 | EP1520017A2 Subtilases and subtilase variants having altered immunogenicity |
| 04/06/2005 | EP1520015A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/06/2005 | EP1520010A2 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 04/06/2005 | EP1520009A2 Method for preparing animal or human adult stem cells and therapeutic use thereof |
| 04/06/2005 | EP1520008A1 Animal protein free media for cultivation of cells |
| 04/06/2005 | EP1519962A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
| 04/06/2005 | EP1519958A2 Humanized monoclonal antibody hpam4 |
| 04/06/2005 | EP1519957A2 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519755A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 04/06/2005 | EP1519747A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1519737A2 Fibrin nanoparticles and uses thereof |
| 04/06/2005 | EP1519650A2 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 04/06/2005 | EP1490475A4 Muscle cells and their use in cardiac repair |
| 04/06/2005 | EP1436410A4 Use of hcv core antigen assay for screening of anti-viral compounds |
| 04/06/2005 | EP1326983B1 Gene cluster for ramoplanin biosynthesis |
| 04/06/2005 | EP1284997B1 Therapeutic compounds for ovarian cancer |
| 04/06/2005 | EP1244776B1 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 04/06/2005 | EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 04/06/2005 | EP1212100B1 Delivery system for antidandruff agent |
| 04/06/2005 | EP1177424A4 Multistage electromagnetic separator for purifying cells, chemicals and protein structures |
| 04/06/2005 | EP1117769B1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2005 | EP0824594B1 Improved methods for transfecting t cells |
| 04/06/2005 | EP0769048B1 Compartmentalized tissue culture flask |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | EP0553244B2 Targeted immunostimulation with bispecific reagents |
| 04/06/2005 | CN1605028A Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 04/06/2005 | CN1605023A Filtration system and method for obtaining a cytology layer |
| 04/06/2005 | CN1604967A Isolation tool for viable c-kit expressing cells |
| 04/06/2005 | CN1604966A Direct targeting binding proteins |
| 04/06/2005 | CN1604965A 生长激素融合蛋白 Growth hormone fusion protein |
| 04/06/2005 | CN1604964A Ashbya gossypii enzymes |
| 04/06/2005 | CN1604962A Cell constructs cultured in vitro, preparation and uses |
| 04/06/2005 | CN1604961A Avian embryo particulate biomass for the production of virus antigens |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604795A Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/06/2005 | CN1603409A Plant promoter and its application |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1195864C Slowviral vector |